홈 › 유방암 › 워싱턴

워싱턴의 유방암 임상 시험

유방암 관련 연구 50개가 워싱턴 내 여러 지역에서 참여자를 모집하고 있습니다.

워싱턴의 도시

공식 연구 텍스트(영어)

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Kadlec Clinic Hematology and Oncology, Kennewick
Swedish Medical Center, Seattle

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT05894239

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

Cancer Care Northwest, Spokane

피험자 모집 중1상

18세 ~ 55세 · 여성 · 2026. 11. 12. 업데이트됨 · NCT07310420

An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

Fred Hutchinson Cancer Research Center, Seattle

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07222267

BostonGene and Exigent Genomic INsight Study

Northwest Medical Specialities, Puyallup

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06272864

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

PeaceHealth Saint Joseph Medical Center, Bellingham
Swedish Cancer Institute-Issaquah, Issaquah
FHCC South Lake Union, Seattle
외 2개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT03418961

Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

Research Facility, Seattle

피험자 모집 중1/2상

전 연령 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06590857

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Fred Hutchinson Cancer Center ( Site 0069), Seattle
Cancer Care Northwest ( Site 0003), Spokane
Northwest Medical Specialties, PLLC ( Site 0067), Tacoma

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06966700

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Fred Hutchinson Cancer Center, Seattle

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07007559

The Vanguard Study: Testing a New Way to Screen for Cancer

Madigan Army Medical Center, Tacoma

피험자 모집 중건강한 지원자 환영

45세 ~ 75세 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT06995898

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Fred Hutchinson Cancer Research Center, Seattle

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06324357

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Northwest Medical Specialties, PLLC, Puyallup
Fred Hutch Cancer Center, Seattle
MultiCare Cancer Institute, Tacoma

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07214532

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Swedish Cancer Institute - Edmonds, Edmonds
Providence Regional Cancer Partnership, Everett
UW Medicine Valley Medical Center, Renton
외 5개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07174336

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Swedish Cancer Institute - Edmonds Campus, Edmonds
Providence Regional Cancer Partnership, Everett
Swedish Cancer Institute - Issaquah, Seattle
외 2개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06790693

E-Mindfulness Approaches for Living After Breast Cancer

PeaceHealth Saint Joseph Medical Center, Bellingham
PeaceHealth United General Medical Center, Sedro-Woolley
Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale

피험자 모집 중3상

18세 ~ 50세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06748222

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Providence Regional Cancer System-Aberdeen, Aberdeen
PeaceHealth Saint Joseph Medical Center, Bellingham
Providence Regional Cancer System-Centralia, Centralia
외 20개

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Swedish Cancer Institute, Everett

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05579366

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Kaiser Permanente Bellevue Medical Center, Bellevue
PeaceHealth Saint Joseph Medical Center, Bellingham
Swedish Cancer Institute-Edmonds, Edmonds
외 8개

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06418204

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Providence Regional Cancer System-Aberdeen, Aberdeen
FHCC Overlake, Bellevue
PeaceHealth Saint Joseph Medical Center, Bellingham
외 26개

피험자 모집 중3상

18세 ~ 60세 · 여성 · 2026. 11. 4. 업데이트됨 · NCT05879926

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Northwest Medical Specialties, PLLC ( Site 0062), Tacoma

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07060807

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Fred Hutchinson Cancer Center at Overlake Cancer Center, Bellevue
Northwest Medical Specialties, Bonney Lake
Northwest Medical Specialties, Federal Way
외 7개

피험자 모집 중3상

60세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT06377852

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Northwest Medical Specialties, PLLC, Tacoma

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT07173751

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Northwest Medical Specialties, Puyallup
Northwest Cancer Specialists, Vancouver

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT07102381

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Providence Regional Cancer System - Aberdeen, Aberdeen
Providence Regional Cancer System - Centralia, Centralia
Providence Regional Cancer System - Lacey, Lacey
외 3개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT07062965

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Fred Hutchinson Cancer Center, Seattle

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT06993844

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

Fred Hutchinson Cancer Center, Seattle

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06757634

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of Washington, Fred Hutchinson Cancer Center, Seattle

피험자 모집 중1/2상

12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

Research Site, Puyallup

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT07205822

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Fred Hutchinson Cancer Center, Seattle

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06625775

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, Tacoma

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06103864

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site, Olympia
Clinical Trial Site, Seattle
Clinical Trial Site, Vancouver

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07085767

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Swedish Medical Center, Seattle

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT06618287

ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions

University of Washington, Seattle

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06085833

BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer

Fred Hutchinson Cancer Research Center, Seattle

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06756932

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Fred Hutchinson Cancer Center, Seattle

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06253871

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

Cancer Care Northwest, Spokane Valley

피험자 모집 중관찰 연구

18세 ~ 99세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07211178

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Cancer Care Northwest-1 (601 S. Sherman), Spokane
Cancer Care Northwest_2 (605 E. Holland), Spokane
Cancer Care Northwest, Spokane Valley

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06072612

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

Fred Hutch Cancer Research, Seattle

피험자 모집 중1/2상

18세 ~ 100세 · 모든 성별 · 2026. 8. 27. 업데이트됨 · NCT06726148

Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer

Fred Hutch/University of Washington Cancer Consortium, Seattle

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 8. 14. 업데이트됨 · NCT06518057

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

University Of Washington, Seattle

피험자 모집 중1상

18세 ~ 100세 · 모든 성별 · 2026. 7. 29. 업데이트됨 · NCT06562192

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

University of Washington School of Medicine, Seattle

피험자 모집 중2상

8세 이상 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT05503797

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.